scispace - formally typeset
S

Stefan J. Riedl

Researcher at Sanford-Burnham Institute for Medical Research

Publications -  45
Citations -  5143

Stefan J. Riedl is an academic researcher from Sanford-Burnham Institute for Medical Research. The author has contributed to research in topics: Caspase & Apoptosis. The author has an hindex of 27, co-authored 45 publications receiving 4722 citations. Previous affiliations of Stefan J. Riedl include Discovery Institute & Max Planck Society.

Papers
More filters
Journal ArticleDOI

The apoptosome: signalling platform of cell death

TL;DR: The formation of the apoptosome and the activation of its effector, caspase-9, reveals a sophisticated mechanism that might be more common than was initially thought.
Journal ArticleDOI

Structural Basis for the Inhibition of Caspase-3 by XIAP

TL;DR: The crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resolution of 2.7 A, is reported, revealing the structural basis for inhibition and the mechanism of inhibition is due to a steric blockade prohibitive of substrate binding.
Journal ArticleDOI

XIAP inhibits caspase‐3 and ‐7 using two binding sites: evolutionarily conserved mechanism of IAPs

TL;DR: It is shown that the BIR2 domain contributes substantially to inhibition of executioner caspases, and it is predicted that the origin of the death stimulus should dictate the efficiency of inhibition by XIAP.
Journal ArticleDOI

The Fas–FADD death domain complex structure unravels signalling by receptor clustering

TL;DR: The result is a regulatory Fas–FADD complex bridge governed by weak protein–protein interactions revealing a model where the complex itself functions as a mechanistic switch that prevents accidental DISC assembly, yet allows for highly processive DISC formation and clustering upon a sufficient stimulus.
Journal ArticleDOI

The Nod-like receptor (NLR) family: a tale of similarities and differences.

TL;DR: It is revealed that NLRs posses a domain architecture similar to the apoptotic initiator protein Apaf-1, suggesting a similar biochemical behaviour in catalytic activity and oligomerization for individual NLRs.